Home > Insider Trading > Filing (0001209191-17-041859)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1077183	Neogenomics Inc	NEO	Services-Testing Laboratories (8734)	742897368

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1640500	Jennifer Balliet	12701 Commonwealth Drive Suite 9 Fort Myers FL 33913	Vp And Chief Culture Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2017-06-22	10,723	$8.49	0	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Reported Derivative Holdings

Sec. Name	Sec. Type	Price	Date	Expiration Date	Amount	Remaning Holdings	Nature of Ownership
Common Stock	Stock Option (Right to Buy)	$3.76	2014-04-16	2018-04-16	7,500	7,500	Direct
Common Stock	Stock Option (Right to Buy)	$3.45	2015-03-05	2019-03-05	15,000	15,000	Direct
Common Stock	Stock Option (Right to Buy)	$4.78	2016-05-04	2020-05-04	120,000	120,000	Direct
Common Stock	Stock Option (Right to Buy)	$7.15	2017-04-20	2021-04-20	50,000	50,000	Direct
Common Stock	Stock Option (Right to Buy)	$7.52	2018-04-28	2022-04-28	60,000	60,000	Direct
Common Stock	Restricted Stock	$0.00	2018-05-25		20,000	20,000	Direct

Expiration Date	Amount	Remaning Holdings	Nature of Ownership
2018-04-16	7,500	7,500	Direct
2019-03-05	15,000	15,000	Direct
2020-05-04	120,000	120,000	Direct
2021-04-20	50,000	50,000	Direct
2022-04-28	60,000	60,000	Direct
	20,000	20,000	Direct

Footnotes

On April 16, 2013, Jennifer Balliet was granted 7,500 stock options. These options vest ratably over the first three anniversary dates of the grant date.
On March 5, 2014, Jennifer Balliet was granted 15,000 stock options. The options vest ratably over the first three anniversary dates of the grant date.
On May 4, 2015, Jennifer Balliet was granted 120,000 stock options. The options vest ratably over the first three anniversary dates of the grant date.
On April 20, 2016, Jennifer Balliet was granted 50,000 stock options. These options vest ratably over the first three anniversary dates of the grant date.
On April 28, 2017, Jennifer Balliet was granted 60,000 stock options. The options vest ratably over the first three anniversaries of the grant date.
Each restricted stock unit represents the contingent right to receive one share of common stock upon vesting of the unit.
Restricted stock will vest as follows; 6,666 units will vest on May 25, 2018 and 6,667 units will vest on May 25, 2019 and 2020.
These restricted stock units will terminate upon the earliest of death, termination of employment or the last vesting date.